Amyloid Light-chain Amyloidosis Clinical Trials
2 recruiting trials for Amyloid Light-chain Amyloidosis. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT07110844
Teclistamab-Daratumumab in AL Amyloidosis
The purpose of this study is to investigate whether teclistamab-daratumumab combination is effective and safe in AL amyloidosis. The study treatment is divided into cycles (C)...
Sponsor: Suzanne Lentzsch, MDEnrolling: 251 location
RECRUITINGNCT06455748
Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of...
This is a prospective and single arm clinical study. The goal of this clinical trial is to observe and evaluate the efficacy and safety of Daratumumab/daratumumab and...
Sponsor: Yongyong MAEnrolling: 201 location